ICON plc (NASDAQ:ICLR), a leading global provider of outsourced drug and device development and commercialization services with an adjusted market capitalization of $13.8 billion, faces a complex ...

The DCF model suggests that ICON is undervalued by 98.23%. Between 2018 and 2024, the company's revenues increased by 219.04% and by 145.30%, respectively. This year, ICLR will implement a program to ...

Leveraging AI to help analyze and visualize data gathered from a variety of data sets enables data-driven insights and fast analysis without the high costs of talent and technology. In today's ...